Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K
Immunological Memory01:23

Immunological Memory

15.0K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
15.0K
Development of Immunocompetence01:22

Development of Immunocompetence

778
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
778
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

922
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
922
Cancer Vaccines01:30

Cancer Vaccines

939
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
939

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world economic comparison of preemptive kidney transplant vs maintenance dialysis in patients with end-stage kidney disease.

Journal of medical economics·2026
Same author

Safety of BNT162b2 COVID-19 Vaccine in Pregnancy: A Systematic Review.

Infectious diseases and therapy·2026
Same author

Mortality and transitions-of-care after COVID-19 hospitalization among US Medicare patients: a retrospective claims analysis.

BMC geriatrics·2026
Same author

Severity of COVID-19 Omicron Variants: A Global Systematic Review.

Infectious diseases and therapy·2026
Same author

Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.

The Lancet. Infectious diseases·2026
Same author

Prospective Respiratory Outcomes from Tracking and Evaluating Community-based TeSting (Project PROTECTS): a community-based, prospective study of acute respiratory infections among adults across the USA - cohort profile.

BMJ open·2026
Same journal

Correction to: Home dampness and molds and occurrence of respiratory tract infections in the first 27 years of life: the Espoo Cohort Study.

American journal of epidemiology·2026
Same journal

A SIMPLE AND POWERFUL TEST OF VACCINE WANING.

American journal of epidemiology·2026
Same journal

Association Between maternal body mass index, offspring growth and pubertal timing: results from a longitudinal birth cohort study.

American journal of epidemiology·2026
Same journal

Correction to: Developing a novel algorithm to identify incident and prevalent dementia in Medicare claims-the ARIC Study.

American journal of epidemiology·2026
Same journal

RE: advancing observational research on arts and health: theory-informed approaches using the RADIANCE framework.

American journal of epidemiology·2026
Same journal

Maternal Cesarean Section and Offspring ASD or ADHD Risk: A Nurses' Health Study II Analysis.

American journal of epidemiology·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

9.0K

Enhancing COVID-19 vaccine effectiveness evidence generation using tokenized immunization registries.

Kathleen M Andersen1, Leah J McGrath1, Kristen E Allen1

  • 1Medical Evidence Generation, Pfizer Inc., New York, NY 10001, United States.

American Journal of Epidemiology
|November 13, 2025
PubMed
Summary
This summary is machine-generated.

Integrating state vaccine registries with claims data significantly improves COVID-19 vaccine uptake documentation. This enhanced data capture offers more accurate vaccine effectiveness insights.

Keywords:
COVID-19 vaccinesepidemiologic biasepidemiologic methodsstate vaccine registriestokenization

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.3K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.1K

Related Experiment Videos

Last Updated: Jan 11, 2026

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

9.0K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.3K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.1K

Area of Science:

  • Public Health
  • Health Informatics
  • Immunization Research

Background:

  • Accurate tracking of COVID-19 vaccine uptake is crucial for public health surveillance and policy.
  • Administrative claims data alone may underestimate vaccine coverage.
  • State vaccine registries offer a more comprehensive vaccination record.

Purpose of the Study:

  • To introduce a novel data ecosystem linking claims and registry data.
  • To quantify the improvement in documented COVID-19 vaccine uptake using this integrated approach.
  • To compare vaccine capture rates across different COVID-19 vaccine formulations.

Main Methods:

  • De-identified administrative claims data were tokenized and linked to state vaccine registry data.
  • Vaccine uptake was measured using claims data alone versus claims data supplemented with registry data.
  • Analysis included original wildtype, BA.4/5-adapted bivalent, and XBB.1.5-adapted COVID-19 vaccine formulations.

Main Results:

  • Integration increased documented primary wildtype series uptake from 20% to 57%.
  • Capture of BA.4/5-adapted bivalent and XBB.1.5-adapted vaccines increased from 7% to 10% and 6% to 8%, respectively.
  • Claims data primarily captured vaccinations via drug codes, and Medicaid-insured individuals were less represented.

Conclusions:

  • The addition of state vaccine registries significantly boosted COVID-19 vaccine capture rates (up to 182% for wildtype).
  • Tokenization of claims data to vaccine registries enables more precise vaccine uptake and effectiveness estimations.
  • This novel data ecosystem enhances public health surveillance capabilities for vaccination campaigns.